Results 31 to 40 of about 51,164 (250)

ANTITHROMBOTIC THERAPY AT AN ATRIAL FIBRILLATION: OLD PROBLEMS AND NEW SOLUTIONS

Рациональная фармакотерапия в кардиологии, 2016
The problem of antiplatelet drug choice in patients with atrial fibrillation is discussed. Authors give special attention to new alternative drugs for prevention of thrombotic complications apart from old known antiplatelet drugs.
M. Yu. Gilyarov, V. A. Sulimov
doaj   +1 more source

ANTIPLATELET THERAPY OF ATRIAL FIBRILLATION: FOCUS ON THE ELDERLY

Рациональная фармакотерапия в кардиологии, 2017
Current guidelines for the management of atrial fibrillation (AF) recommend using anticoagulants as first-line drugs for stroke prevention, but in real medical practice antiplatelet drugs are often prescribed to elderly patients.
E. А. Ushkalova, S. K. Zyryanov, E. V. Dumchenko   +2 more
doaj   +1 more source

RESISTANCE TO ANTIPLATELET DRUGS IN PATIENTS WITH ISCHEMIC HEART DISEASE

Рациональная фармакотерапия в кардиологии, 2015
The clinical, cell and genetic factors are distinguished among reasons for resistance to antiplatelet drugs. There are many methods to detect sensitivity to antiplatelet drugs, but they all have disadvantages.
D. H. Aynetdinova, A. E. Udovichenko, V. A. Sulimov   +2 more
doaj   +3 more sources

Progress Analysis of Personalized Antiplatelet Therapy in Patients with Coronary Heart Disease Undergoing Interventional Therapy

Reviews in Cardiovascular Medicine
Coronary atherosclerosis (or coronary heart disease [CHD]) is a common cardiovascular disease that seriously damages human health. Percutaneous coronary stent implantation represents the primary treatment option for severe CHD in clinical practice ...
Ji-tong Yang, Qiu-juan Zhang, Hua Li, Ming-wei Liu   +3 more
doaj   +1 more source

Antiplatelet drugs and the perioperative period: What every urologist needs to know

Indian Journal of Urology, 2009
Antiplatelet agents like aspirin and clopidogrel are widely used for indications ranging from primary and secondary prevention of myocardial infarction or stroke to prevention of coronary stent thrombosis after percutaneous coronary interventions.
Pawan Vasudeva, Apul Goel, Vengetesh K Sengottayan, Satyanarayan Sankhwar, Divakar Dalela   +4 more
doaj   +1 more source

DENTAL CONSIDERATIONS IN PATIENTS TAKING NEW ANTIPLATELET AND ANTICOAGULANT DRUGS [PDF]

Journal of IMAB, 2020
Atherosclerosis and the resulting cardiovascular and cerebrovascular diseases (myocardial infarction, coronary artery disease and stroke) are the leading cause of mortality and morbidity in the developed countries.
Atanaska S. Dinkova, Hristo I. Daskalov, Delian Delev   +2 more
doaj   +1 more source

PHARMACOGENETIC BASES OF INDIVIDUAL SENSITIVITY AND PERSONALIZED ADMINISTRATION OF ANTIPLATELET THERAPY IN DIFFERENT ETHNIC GROUPS

Фармация и фармакология (Пятигорск), 2021
Cardiovascular diseases (CVDs) are the leading cause of disability and mortality worldwide. Increased thrombosis is the trigger point for the development of various CVDs and their complications, and therefore, therapy with P2Y12-receptor inhibitors is ...
B. I. Kantemirova, E. A. Orlova, O. S. Polunina, E. N. Chernysheva, M. A. Abdullaev, D. A. Sychev   +5 more
doaj   +1 more source

Antiplatelet Agents Have a Distinct Efficacy on Platelet Aggregation Induced by Infectious Bacteria

Frontiers in Pharmacology, 2020
Platelets are the cornerstone of hemostasis. However, their exaggerated aggregation induces deleterious consequences. In several diseases, such as infectious endocarditis and sepsis, the interaction between platelets and bacteria leads to platelet ...
Nadji Hannachi, Emma Ogé-Ganaye, Emma Ogé-Ganaye, Jean-Pierre Baudoin, Anthony Fontanini, Denis Bernot, Gilbert Habib, Gilbert Habib, Laurence Camoin-Jau, Laurence Camoin-Jau   +9 more
doaj   +1 more source

Analysis of risk factors for prolong hospitalization in chronic subdural hematoma undergoing single burr hole and drainage

Nepal Journal of Neuroscience, 2021
Introduction Single burr hole surgery for Chronic subdural hematoma (CSDH) is commonly performed neurosurgical procedure with >90% favorable outcome and less hospital stay. However, sometimes hospital stay may be prolonged due to associated prognostic
Sumit Joshi, Prakash Paudel, Damber Bikram Shah, Prasanna Karki, Gopal Raman sharma   +4 more
doaj   +1 more source

Bleeding after tooth extraction in patients receiving anticoagulation/antiplatelet therapy

口腔疾病防治, 2021
Tooth extraction in patients receiving anticoagulation/antiplatelet therapy is often considered contraindicated by many oral and maxillofacial surgeons because of a higher risk of postoperative bleeding.
HUANG Jinxia, SHI Haitao, PAN Jian
doaj   +1 more source